A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy

NCT07483827 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

C3 Glomerulopathy (C3G)
Healthy Adult Participants

Interventions

DRUG: CPV-104/Placebo
DRUG: CPV-104

Sponsor

eleva GmbH